Hydrogels auf Basis von Dextran-Hyaluronsäure

European patent · EP2498830 · In force

Register entry

Publication number
EP2498830
Application number
EP10781753
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 11, 2010
Published
Sep 19, 2012
Granted
Sep 21, 2016
Protection ends at the latest
Nov 10, 2030
Next annual fee due
Nov 30, 2026
IPC classes
A61L 27/20 (2006.01)
A61L 27/52 (2006.01)
A61K 47/48 (2006.01)
Priority
EP 09175724 11.11.2009
PCT application
PCT/NL2010/050751 11.11.2010
PCT publication
WO2011/059325 19.05.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Jan 26, 2024

    Change

    Published in Swissreg on 26.01.2024

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Jun 12, 2019

    Transferred

    Owner
    University of Twente, Institute for Biomedical, Technology and Technical Medicine (MIRA), Drienerlolaan 5, 7522 NB Enschede, Netherlands → Hy2Care B.V., p/a Drienerlolaan 5, Gebouw ZH143 UvT, 7522 NB Enschede, Netherlands

    Published in Swissreg on 12.06.2019

  6. Sep 21, 2016

    Granted

    Published in Swissreg on 21.09.2016

Parties

Holder

Hy2Care B.V.

p/a Drienerlolaan 5, Gebouw ZH143 UvT, 7522 NB Enschede, NL

Inventor

KARPERIEN, Hermanus, Bernardus, Johannes

NL-7151 DJ Eibergen, NL

JIN, Rong

NL-7522 MJ Enschede, NL

MOREIRA TEIXEIRA, Liliana, Sofia

NL-7523 RG Enschede, NL

FEIJEN, Jan

NL-7552 GD Hengelo, NL

DIJKSTRA, Pieter, Jelle

NL-7623 CP Borne, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.